Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Clinical trial NCT05163652 · UNKNOWN

Trial details

NCT number: NCT05163652
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-12-18
Primary completion: 2022-08-30
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.